PATENT CLAIM ANALYSIS

Application Number: 15756454
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "021500"]

Abstract:
The disclosure relates to a pharmaceutical composition comprising any one or combination of PIF peptides or analogs or pharmaceutically acceptable salts thereof. Methods of treating autoimmune disease using the one or a combination of PIF peptide or analogs thereof or pharmaceutically acceptable salts thereof is also disclosed.

Claim (Index 63):
The method of  claim 58 , wherein the at least one pharmaceutical composition is administered via intravenously, intramuscularly, topically, intradermally, transmucosally, subcutaneously, sublingually, transdermally, orally, buccally, intraocularly, intravaginally, intrarectally, intraductally, intrathecally, subdurally, extradurally, intraventricularly, intraarticularly, intraperitoneally, into the pleural cavity, by inhalation, by depot injections, or by implants.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 88.0
- Lexical Diversity: 1.58065
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14009505', '14795581', '12786290', '11381818', '15474639']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7712795798074192
- 35 USC 102 Novelty (BERT): 0.5320124244680902
- Combined Prediction Score: 0.7473528642734864
- Mean Citation Score: 309.377716
- Max Citation Score: 348.2711
- Similarity Product: 211.6622172154486

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test